Tutkimus käsittelee riskirahoituksen ja riskirahoittajien merkitystä biotekniikka-alan yritystoiminnalle. Se kiinnittää erityistä huomiota riskirahoittajien tuomaan lisäarvoon yrityksille varsinkin muussa kuin rahallisessa merkityksessä. Tutkimuksessa verrataan sekä riskirahoitusta...

This study focuses on the non-financial value-added Venture Capital (VC) investors bring to their portfolio companies, especially when these represent early-stage, high-technology and high-growth companies. The study draws attention to the extent and nature of non-financial value-added and...

The paper reports an empirical study on the overall importance and non-financial value-added provided by Venture Capital (VC) investors to their investee firms in biotechnology. The study compares the characteristics of firms that have obtained VC funding with those of firms that have not....

This study focuses on the non-financial value-added Venture Capital (VC) investors bring to their portfolio companies, especially when these represent early-stage, high-technology and high-growth companies. The study draws attention to the extent and nature of non-financial value-added and...

The paper reports an empirical study on the non-financial value-added provided by Venture Capital investors to their investee firms. This study will use a four-class grouping of the various non-financial value-adding capabilities provided by VC firms, namely, scouting, monitoring, signalling and...

This study focuses on the non-financial value-added of venture capital investors (VCs) as perceived by the CEOs of Finnish biotechnology companies. It pays attention to differences in the value-added between informal venture capitalists, private sector venture capitalists and public sector...